Epocrates
Latest round
- Series C
Last raised
- Oct 2004
Total raised
- $41M
Investors
- 5
About Epocrates
Epocrates, Inc.Founded in 1998, Epocrates, Inc. operates in San Francisco, US, providing mobile healthcare solutions.76 mn through its IPO. In January 2013, Epocrates was acquired by Athenahealth, Inc. for USD 293 mn.Epocrates offers a comprehensive suite of digital healthcare solutions, featuring a mobile app that provides healthcare professionals access to a vast database of medical information, including drug interactions and clinical guidelines.87 mn. The company focuses on designing new product features to enhance user experience and anticipates expanding into European markets by 2015, capitalizing on partnerships with pharmaceutical companies to bolster its offerings. The acquisition by Athenahealth in January 2013 for USD 293 mn is expected to enhance Epocrates’ capabilities and outreach.
Who invested in Epocrates
5 investors across 3 rounds
See all investors in Epocrates
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Epocrates
Who invested in Epocrates?
Epocrates has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Epocrates raised?
Epocrates has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Epocrates last raise money?
Epocrates's most recent round on record is a Series C, in Oct 2004.
What does Epocrates do?
Epocrates is a healthcare it company.
Where is Epocrates headquartered?
Epocrates is headquartered in San Francisco, US.
Which VCs invest in companies like Epocrates?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at Epocrates's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series C
Raising like Epocrates? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.